Autoantibodies against the glial glutamate transporter GLT1/EAAT2 in Type 1 diabetes mellitus—Clues to novel immunological and non-immunological therapies.

Saved in:
Bibliographic Details
Title: Autoantibodies against the glial glutamate transporter GLT1/EAAT2 in Type 1 diabetes mellitus—Clues to novel immunological and non-immunological therapies.
Authors: Perego, Carla1 (AUTHOR) carla.perego@unimi.it, Di Cairano, Eliana S.1 (AUTHOR), Galli, Alessandra1 (AUTHOR), Moretti, Stefania1 (AUTHOR), Bazzigaluppi, Elena2 (AUTHOR), Centonze, Victoria Frolich3 (AUTHOR), Gastaldelli, Amalia4 (AUTHOR), Assi, Emma5 (AUTHOR), Fiorina, Paolo5,6 (AUTHOR), Federici, Massimo7 (AUTHOR), Porzio, Ottavia8 (AUTHOR), Bertuzzi, Federico9 (AUTHOR), Davalli, Alberto M.10 (AUTHOR), Folli, Franco1,11 (AUTHOR) franco.folli@unimi.it
Source: Pharmacological Research. Mar2022, Vol. 177, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Description
ISSN:10436618
DOI:10.1016/j.phrs.2022.106130